首页 | 官方网站   微博 | 高级检索  
     


Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA
Authors:Lacroix, Dan   Desrochers, Marc   Castonguay, Andre   Anderson, Alan
Affiliation:1Centre de recherche en cancérologic de I'Université Laval, L'Hôl-Dieu de Québec 11, côte du Palus, Québec G1R 2J6
2Départment de biologie, Université Laval Québec GIK 7P4
3Laboratoire d'étiologie et de chimioprévention du cancer, Ecole de pharmacie, Université Laval Québec G1K 7P4, Canada
Abstract:In all species where it has been tested, the tobacco-specificnitrosamine 4-(methylnitrosainino)-l-(3-pyridyl)-l-butanone(NNK) has been shown to be a potent carcinogen, and NNK andother nitrosamines may play a role in human tobacco-relatedcarcinogenesis. Purified rat CYP2B1 has been shown to metabolizeNNK, and the CYP2B1 gene is expressed constitutively in ratlung. The objectives of this study were to test the capacityof CYP2B1, synthesized from a rat hepatic cDNA in Ad293 cells,to metabolize NNK, and to define the type and the proportionsof the final metabolites produced. Ad293 cells were transfectedwith a CYP2B1 expression vector (pMT2-2Bl), or with a controlvector and incubated in culture medium containing [3H]NNK, afterwhich {alpha}-carbon hydroxylation and pyridine N-oxidation metaboliteswere identified by HPLC analysis and quantitated by scintillationcounting. pMT2-2Bl-transfected cells were capable of catalyzing{alpha}-carbon hydroxylation and pyridine N-oxidation of NNK, althoughthe reduction product 4-(methylnitrosamino)-l-(3-pyridyIH)-butan-l-ol(NNAL)was the major metabolite formed in cells regardless of transfectiontreatment. The total amount of {alpha}-carbon hydroxylation metabolitesproduced by pMT2-2Bl-transfected cells was greater than thatof pyridine N-oxidation metabolites. However, pMT2-2Bl transfectedcells produced sim; ten-fold more pyridine N-oxidation metabolitesand only two-fold more {alpha}-carbon hydroxylation metabolites thancontrol cells. Furthermore, the amount of NNAL-N-oxide was muchlower than that of NNK-N-oxide in the medium of pMT2–2Bl-transfectedcells, even though the amount of available NNAL, resulting fromcarbonyl reduction of NNK, was very high; this suggests thatNNAL is poorly N-oxidized by CYP2B1 compared to NNK. These resultsshow that within living cells NNK was metabolized by CYP2B1via both the pyridine N-oxidation and {alpha}-carbon hydroxylationpathways. However, CYP2B1 preferentially catalyzed pyridineN-oxidation, which is considered to be a deactivation reaction.
Keywords:
本文献已被 Oxford 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号